Search Results

Ordering information regarding a Deamidated Gliadin Peptide (DGP) Antibody, IgA test for Clinical Diagnostic Laboratories. Deamidated Gliadin Peptide (DGP) Antibody, IgA Ordering Recommendation Acceptable single screening test for celiac disease. IgA testing recommended to identify IgA deficiency. Use IgA test in individuals who are IgA competent. May be useful in diagnosing children <2 years who test negative for tTG and EMA antibodies. May aid in monitoring adherence to gluten-free diet. Celiac Disease Reflexive Cascade (2008114 ) or Tissue Transglutaminase (tTG) Antibody, IgA (0097709 ) is the preferred test for screening patients with suspected celiac disease. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported 1-2 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transport 0.5 mL serum. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or grossly lipemic specimens. Remarks: Plasma. Hemolyzed or severely lipemic specimens. Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval 19 Units or less 20-30 Units Negative Weak Positive 31 Units or greater Positive Interpretive Data Note Human recombinant tTG antigen is utilized in this assay CPT Code 86258 Components Component Chart Name Deamidated Gliadin Peptide (DGP) Ab, IgA Component Test Code 0051357 LOINC 63453-5 Aliases Celiac Disease Antibodies Coeliac Disease Antib odies Deamidated Gliadin Antibodies (DGP) Deaminated Gliadin Peptide Antibodies DGP DGP Ab DGP IgA

Ordering information regarding a Cardiolipin Antibody, IgM test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgM Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is highly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Beta-2 Glycoprotein 1 Antibodies, IgG and IgM (0050321 ). Cardiolipin Antibodies, IgG and IgM (0099344 ) is preferred. Mnemonic AC-IGM Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval <=12 MPL Negative 13-19 MPL Indeterminate 20-80 MPL Low to Moderately Positive 81 MPL or above High Positive Interpretive Data The persistent presence of IgG and/or IgM cardiolipin (CL) antibodies in moderate or high levels (greater than 40 GPL and/or greater than 40 MPL units) is a laboratory criterion for the diagnosis of antiphospholipid syndrome (APS). Persistence is defined as moderate or high levels of IgG and/or IgM CL antibodies detected in two or more specimens drawn at least 12 weeks apart (J Throm Haemost. 2006;4:295-306). Lower positive levels of IgG and/or IgM CL antibodies (above cutoff but less than 40 GPL and/or less than 40 MPL units) may occur in patients with the clinical symptoms of APS; therefore, the actual significance of these levels is undefined. Results should not be used alone for diagnosis and must be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests. Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86147 Components Component Chart Name Cardiolipin Antibody IgM Component Test Code 0050902 LOINC 3182-3 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip

Ordering information regarding a Allergen, Food, Egg Whole test for Clinical Diagnostic Laboratories. Allergen, Food, Egg Whole Ordering Recommendation Not recommended for initial thyroid disorders testing. Distinguish thyroid autoimmune disorders from nonautoimmune disease or hypothyroidism. Mnemonic EGGWHOLE Methodology Quantitative ImmunoCAP Fluorescent Enzyme Immunoassay Performed Mon-Sat Reported 1-3 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Multiple patient encounters should be avoided. Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval Probability of IgE Mediated Clinical Reaction Reporting Range (reported in kU/L) Class Scoring No significant level detected Less than 0.10 0 0.10 - 0.34 0.35 - 0.70 Clinical relevance undetermined Low 0/1 1 0.71 - 3.50 3.51 - 17.50 Moderate High 2 3 17.51 - 50.00 50.01 - 100.00 Very high Very high 4 5 Greater than 100.00 Very high 6 Interpretive Data Allergen results of 0.10-0.34 kU/L are intended for specialist use as the clinical relevance is undetermined. Even though increasing ranges are reflective of increasing concentrations of allergen-specific IgE, these concentrations may not correlate with the degree of clinical response or skin testing results when challenged with a specific allergen. The correlation of allergy laboratory results with clinical history and in vivo reactivity to specific allergens is essential. A negative test may not rule out clinical allergy or even anaphylaxis. Compliance Category: FDA Note Components CPT Code 86003 Component Chart Name Allergen, Food, Egg Whole IgE Component Test Code 0055381 LOINC 7291-8 Aliases ImmunoCAP f245

Clinical Diagnostic Laboratories provides fast, reliable lab testing for Skilled Nursing Facilities in the DMV area. From routine blood work to infectious disease panels, mobile phlebotomy, and customized testing solutions, we help nursing homes deliver better resident care. Why You Should Choose Clinical Diagnostic Laboratories FAST TURNAROUND TIMES Get results within 24–48 hours, helping your nursing home make faster, informed care decisions. CUSTOMIZED TESTING PANELS We design testing panels tailored to your residents’ unique needs, ensuring the right answers every time. MOBILE PHLEBOTOMY Our skilled team comes directly to your facility, reducing stress for residents and saving staff valuable time. HIPAA COMPLIANT We safeguard all patient information with the highest standards of security and confidentiality. REGULATORY COMPLIANCE CDL meets all federal and state regulations, giving your facility peace of mind and audit-ready confidence. DEDICATED ACCOUNT MANAGER Every partner receives a dedicated account manager to ensure smooth communication and personalized support. SIMPLE REPORTING Our clear, easy-to-read reports help your staff make confident care decisions without confusion. EASY TO ACCESS PATIENT PORTAL Residents and providers can securely view results anytime through our convenient online portal. Lab Testing Designed for Skilled Nursing Facilities To play, press and hold the enter key. To stop, release the enter key. Experience Expert Lab Testing Services Whether your Skilled Nursing Facility requires routine blood work or advanced infectious disease testing, Clinical Diagnostic Laboratories is here to support you. Contact us today to schedule a consultation or explore our full range of services. Contact Us

Ordering information regarding a Tissue Transglutaminase (tTG) IgG test for Clinical Diagnostic Laboratories. Tissue Transglutaminase (tTG) IgG Ordering Recommendation Recommended single screening test for IgA-deficient individuals with suspected celiac disease. (IgA testing recommended to identify IgA deficiency.) May aid in monitoring adherence to gluten-free diet in celiac disease confirmed patients. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported 1-2 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Remove serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Refrigerated. Remarks: Plasma. Hemolyzed or severely lipemic specimens. Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval 5 U/mL or less 6-9 U/mL Negative Weak Positive 10 U/mL or greater Positive Interpretive Data The tTG IgG assay may aid in the diagnosis of gluten-sensitivity enteropathy (i.e., celiac disease, dermatitis herpetiformis) in tTG IgA negative patients with confirmed IgA deficiency. A negative tTG IgG test alone does not rule out gluten-sensitive enteropathy. Note Human recombinant tTG antigen is utilized in this assay CPT Code 86364 Components Component Chart Name Tissue Transglutaminase (tTG) Ab, IgA Component Test Code 0056009 LOINC 56537-4 Aliases Tissue Transglutaminase Transglu taminase tTG tTG IgG

Services for Government Agencies Clinical Diagnostics Laboratories does not currently work with any government agencies but we are registered in the same database and are a female-owned and operated, minority company. Clinical Diagnostics Laboratories is always available and open for opportunities. If you're interested in learning more about our services or are interested in working with us, please contact us for more information. CONTACT US

Ordering information regarding a Cardiolipin Antibody, IgA test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgA Ordering Recommendation Preferred second-line test when seronegative antiphospholipid syndrome (APS) is strongly suspected. Order incrementally or concurrently with other noncriteria antiphospholipid antibody tests. Mnemonic CARDIO IGA Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval <=12 MPL Negative 13-19 MPL Indeterminate 20-80 MPL Low to Moderately Positive 81 MPL or above High Positive Interpretive Data The persistent presence of IgG and/or IgM cardiolipin (CL) antibodies in moderate or high levels (greater than 40 GPL and/or greater than 40 MPL units) is a laboratory criterion for the diagnosis of antiphospholipid syndrome (APS). Persistence is defined as moderate or high levels of IgG and/or IgM CL antibodies detected in two or more specimens drawn at least 12 weeks apart (J Throm Haemost. 2006;4:295-306). Lower positive levels of IgG and/or IgM CL antibodies (above cutoff but less than 40 GPL and/or less than 40 MPL units) may occur in patients with the clinical symptoms of APS; therefore, the actual significance of these levels is undefined. Results should not be used alone for diagnosis and must be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests. Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86147 Components Component Chart Name Cardiolipin Antibody IgM Component Test Code 0050902 LOINC 3182-3 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip

Ordering information regarding a Thyroid Stimulating Hormone test for Clinical Diagnostic Laboratories. Thyroid Stimulating Hormone (TSH) Ordering Recommendation Preferred test for initial screening and monitoring of thyroid function. Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Plasma separator tube, or serum separator tube SST Specimen Preparation: Separate serum or plasma from cells ASAP or within 2 hours of collection. Allow serum specimen to clot completely at room temperature. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation from cells: Ambient: Calcium and CO2: 4 hours, All others: 24 hours; Refrigerated: 1 week; Frozen: 2 weeks Reference Interval Components Available Separately Reference Interval Interpretive Data Note CPT Code 84443 Components Component Test Code Component Chart Name LOINC 0070145 Thyroid Stimulating Hormone 3016-3 Aliases Thyrotropin TSH TSH, Pregnancy

View a complete list of participating insurances here at Clinical Diagnostic Laboratories. Contact us for more information. PARTICIPATING INSURANCE COMPANIES Clinical Diagnostics Laboratories will file all claims with the below-listed insurance companies. The list below is not a complete list of Health plans with which CDL participates and is subject to change over time. There may be exceptions in certain areas or for certain members or plans. If you have any questions or do not see your insurance company listed here, please contact us. AARP Adventist HealthCare Aetna (PPO) American Postal Workers Union (APWU) AmeriGroup Health AmeriHealth Anthem Assurant Health Beechstreet Benefit Plan Administrators VA Blue Cross Blue Shield of VA PPO, KeyCare, Cova, Medicare Advantage PPO Anthem Blue Cross (PPO, Medicare PPO)Blue Cross Blue Shield of West VA BRMS Capital Blue Cross (PPO Only) Care Improvement Plus-United Health CareFirst BCBS CareLink CareNet Celtic Insurance ChoiceCare Cigna (Multiplan) Cofinity Compass Rose Conifer Health Solution CoreSource Corvel Coventry National PPO Emblem Health (PPO Only) Empire BCBS (PPO Only) Federal and State Benefit Health Plans FEHBP FedMed Inc First Health National PPO Network Fortis Insurance -Assurant Galaxy Health Network GEHA-(First Health) Geisinger Health Great West HealthAmerica HealthPartners Network HealthScope Services HealthSmart Preferred Networks Highmark BCBS (PPO Only) Horizon BCBS (PPO Only) Humana (All Plans) InterPlan Health Group-HealthSmart John Alden Insurance -Assurant Johns Hopkins Healthcare MagnaCare Mail Handlers Benefit Plan Maryland Physicians Care (MPC) MedCost (NovaNet) Medical Mutual Meritain Health Multiplan National Network NALC- Cigna, Multiplan National Capital PPO, Health Link National Care Network NCN National Claims Administrative Services (NCAS) NovaNet PPO OneNet PPO (United Health Care) Optima Health Network-Valley Health Net Paramount Health Care PayerFusion POMCO Prime Health Services Private Healthcare (PMCS) Pyramid Life Insurance Company Riverside Health(Maryland HealthChoice) Ryan White HIV/Aids Program SAMBA FEP StarMark Insurance Stratrose PPO, NPPN SummaCare PPO (Multiplan, PHCS) SuperMed PPO-1st Medical The Health Plan Three Rivers Provider Network Unicare UnitedHealthcare Virginia Health Network-MedCost Ultra, VHN Plus USA MCO Government Health Plans Medicaid VA, MD, and DC Medicare Advantage PPO Medicare Supplement Railroad Medicare Traditional Medicare Tricare Health Net Federal Services Humana Military TriCare for Life TriWest SCHEDULE AN APPOINTMENT Last Name Email Phone Type your message here... Submit Thanks for submitting! A member of our team will respond to your inquiry as soon as possible.

Ordering information regarding a Cardiolipin Antibody, IgG test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgG Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is strongly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Beta-2 Glycoprotein 1 Antibodies, IgG and IgM (0050321 ). Cardiolipin Antibodies, IgG and IgM (0099344 ) is preferred. Mnemonic AC-IGG Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval <=14 GPL Negative 15-19 GPL Indeterminate 20-80 GPL Low to Moderately Positive 81 GPL or above High Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Cardiolipin Antibody IgG Component Test Code 0050901 LOINC 3181-5 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip